Literature DB >> 20544226

Aprepitant against pruritus in patients with solid tumours.

Bruno Vincenzi1, Maria Elisabetta Fratto, Daniele Santini, Giuseppe Tonini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20544226     DOI： 10.1007/s00520-010-0895-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  5 in total

1.  Aprepitant as an antipruritic agent?

Authors:  Arnaud Duval; Louis Dubertret
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

Review 2.  Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.

Authors:  Ryo Saito; Yukio Takano; Hiro-O Kamiya
Journal:  J Pharmacol Sci       Date:  2003-02       Impact factor: 3.337

Review 3.  What lies beneath the surface of the itch in adults?

Authors:  David Weldon
Journal:  Allergy Asthma Proc       Date:  2007 Mar-Apr       Impact factor: 2.587

Review 4.  Antiemetic control: toward a new standard of care for emetogenic chemotherapy.

Authors:  Rudolph M Navari
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

5.  Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.

Authors:  G Kesava Reddy; Richard J Gralla; Paul J Hesketh
Journal:  Support Cancer Ther       Date:  2006-04-01
  5 in total
  13 in total

Review 1.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  [New treatment options for chronic pruritus].

Authors:  C Zeidler; B Pfleiderer; S Ständer
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

Review 3.  Basic mechanisms of itch.

Authors:  C Potenzieri; B J Undem
Journal:  Clin Exp Allergy       Date:  2011-06-06       Impact factor: 5.018

Review 4.  Targeted treatment of pruritus: a look into the future.

Authors:  H L Tey; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

Review 5.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

6.  Neurokinin 1 Receptor Antagonists for Pruritus.

Authors:  Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal:  Drugs       Date:  2021-03-06       Impact factor: 9.546

7.  Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

Authors:  Johanna S Song; Marianne Tawa; Nicole G Chau; Thomas S Kupper; Nicole R LeBoeuf
Journal:  BMC Cancer       Date:  2017-03-16       Impact factor: 4.430

Review 8.  NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.

Authors:  Marcelina Pojawa-Gołąb; Kamila Jaworecka; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2019-06-12

9.  Paraneoplastic pruritus presenting with Hodgkin's lymphoma: a case report.

Authors:  Jose Javier Arenas Villafranca; Marga Garrido Siles; María Casanova; Begoña Tortajada Goitia; Antonio Rueda Domínguez
Journal:  J Med Case Rep       Date:  2014-09-08

Review 10.  Aprepitant for the Treatment of Chronic Refractory Pruritus.

Authors:  Alice He; Jihad M Alhariri; Ronald J Sweren; Madan M Kwatra; Shawn G Kwatra
Journal:  Biomed Res Int       Date:  2017-09-19       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.